SF Healthcare Week: Nicole Paulk shares an update on her company Siren Biotechnology and describes what the environment is like for smaller companies in biotech right now

She describes how Siren is being built with a universal AAV platform, and is nearing its first IND in oncology. Plus, the fundraising environment around this year's conference, and how gene therapy might be insulated from the competition from China that other areas have been feeling.